Fig.1From: Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical reviewChemical structures of small compounds approved by the FDA for use in treating various cardiovascular diseases between 2015 and June 2020Back to article page